Deciding whether to invest in a good idea is hard. Even when its potential is clearly explained. Trying to make that evaluation without a solid explanation is an exercise in needless frustration. I’ve talked about the role of a compelling executive summary to get an investor’s initial attention and secure their agreement to take a pitch meeting. But what should that investor expect out of the ensuing pitch deck?
- Delta Development Team Equips Kenosha WI EMS Carry Blood to the Frontline
- NuvOx Announces Positive Results 1st Cohort Phase Ib Trial
- Tech Parks Arizona Economic Impact
- Delta Development Team Exceeds New Prehospital Blood Transfusion Standards
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics